• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. PENUMBRA SYSTEM REPERFUSION CATHETER 032; NRY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. PENUMBRA SYSTEM REPERFUSION CATHETER 032; NRY Back to Search Results
Catalog Number PSC032
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Reocclusion (1985)
Event Date 03/21/2011
Event Type  Injury  
Event Description
The patient was undergoing a thrombectomy procedure using the penumbra system reperfusion catheter 054/032 and separator 054/032.During the procedure, a reperfusion catheter 054 was used over a reperfusion catheter 032 and a transend microwire (200cm).After the wire and reperfusion catheter 032 were advanced mid lacerum, they were removed and aspiration with the reperfusion catheter 054 was performed for about 15 minutes.A follow up angiogram demonstrated there was no filling defect in the internal carotid artery (ica) but also demonstrated a "cut off at the distal ipsilateral a2 branch." then, the procedure to recanalize the right mca vessel commenced.The reperfusion catheter 054 was advanced into the right middle cerebral artery (mca) and aspiration ran for about 25 minutes.Just after, an angiogram was performed and demonstrated partial recanalization of the m1, distal slow antegrade flow into the inferior division of the mca.A follow-up angiogram taken minutes later demonstrated complete re-occlusion of the mca.To treat the re-occlusion of the m1, the treating physician used a prowler plus select catheter, advancing it over a transend microwire into the m1 segment.The microwire was removed and an enterprise stent (4.5 x 37mm) was utilized as a "stentreiver".The angiogram then showed significant recanalization, however a few minutes later, the vessel again re-occluded.To treat the second re-occlusion of the m1, an apex balloon (2 x 15mm) was used to perform a balloon angioplasty, yielding some improvement of blood flow.Then a vision stent (2 x 8mm) was deployed in the m1 segment with further restoration of flow to the distal portion of the mca.Finally, the physician moved forward with treating the right a2 clot.A gateway balloon (2 x 15mm) was used to conduct an angioplasty.An apex balloon (2 x 15mm) was used soon after, which allowed for some restoration to the blood flow.The final angiogram demonstrated significant improvement of flow in both the mca and aca territories.No further issues were detected and no device malfunctions occurred during the procedure.The relationship between the device and the event are definite with moderate in severity.
 
Manufacturer Narrative
Conclusion: re-occlusion (distal embolization) is a known and anticipated complication with these types of procedures and is noted in the device labeling.Therefore, it was determined that the reported event was an anticipated procedural complication.This mdr is associated with mdr 3005168196-2014-00287, 00289 and 00290.Device was disposed of by the hospital.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENUMBRA SYSTEM REPERFUSION CATHETER 032
Type of Device
NRY
Manufacturer (Section D)
PENUMBRA, INC.
1351 harbor bay parkway
alameda CA 94502
Manufacturer (Section G)
PENUMBRA, INC.
1351 harbor bay parkway
alameda CA 94502
Manufacturer Contact
kathleen kidd
1351 harbor bay parkway
alameda, CA 94502
5107483200
MDR Report Key3803525
MDR Text Key4386701
Report Number3005168196-2014-00288
Device Sequence Number1
Product Code NRY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K072718
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,User Facility,Company Representative
Reporter Occupation Health Professional
Type of Report Initial
Report Date 01/24/2013
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/09/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Catalogue NumberPSC032
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/24/2013
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age80 YR
-
-